Cargando…

Therapeutic Drug Monitoring of Ganciclovir Treatment for Cytomegalovirus Infections Among Immunocompromised Children

Detalles Bibliográficos
Autores principales: Stockmann, Chris, Sherwin, Catherine M. T., Knackstedt, Elizabeth D., Hersh, Adam L., Pavia, Andrew T., Spigarelli, Michael G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289335/
https://www.ncbi.nlm.nih.gov/pubmed/26962197
http://dx.doi.org/10.1093/jpids/piw008
_version_ 1783545440368590848
author Stockmann, Chris
Sherwin, Catherine M. T.
Knackstedt, Elizabeth D.
Hersh, Adam L.
Pavia, Andrew T.
Spigarelli, Michael G.
author_facet Stockmann, Chris
Sherwin, Catherine M. T.
Knackstedt, Elizabeth D.
Hersh, Adam L.
Pavia, Andrew T.
Spigarelli, Michael G.
author_sort Stockmann, Chris
collection PubMed
description
format Online
Article
Text
id pubmed-7289335
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72893352020-06-15 Therapeutic Drug Monitoring of Ganciclovir Treatment for Cytomegalovirus Infections Among Immunocompromised Children Stockmann, Chris Sherwin, Catherine M. T. Knackstedt, Elizabeth D. Hersh, Adam L. Pavia, Andrew T. Spigarelli, Michael G. J Pediatric Infect Dis Soc Letter to the Editor Oxford University Press 2016-06 2016-03-08 /pmc/articles/PMC7289335/ /pubmed/26962197 http://dx.doi.org/10.1093/jpids/piw008 Text en © The Author 2016. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Letter to the Editor
Stockmann, Chris
Sherwin, Catherine M. T.
Knackstedt, Elizabeth D.
Hersh, Adam L.
Pavia, Andrew T.
Spigarelli, Michael G.
Therapeutic Drug Monitoring of Ganciclovir Treatment for Cytomegalovirus Infections Among Immunocompromised Children
title Therapeutic Drug Monitoring of Ganciclovir Treatment for Cytomegalovirus Infections Among Immunocompromised Children
title_full Therapeutic Drug Monitoring of Ganciclovir Treatment for Cytomegalovirus Infections Among Immunocompromised Children
title_fullStr Therapeutic Drug Monitoring of Ganciclovir Treatment for Cytomegalovirus Infections Among Immunocompromised Children
title_full_unstemmed Therapeutic Drug Monitoring of Ganciclovir Treatment for Cytomegalovirus Infections Among Immunocompromised Children
title_short Therapeutic Drug Monitoring of Ganciclovir Treatment for Cytomegalovirus Infections Among Immunocompromised Children
title_sort therapeutic drug monitoring of ganciclovir treatment for cytomegalovirus infections among immunocompromised children
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289335/
https://www.ncbi.nlm.nih.gov/pubmed/26962197
http://dx.doi.org/10.1093/jpids/piw008
work_keys_str_mv AT stockmannchris therapeuticdrugmonitoringofganciclovirtreatmentforcytomegalovirusinfectionsamongimmunocompromisedchildren
AT sherwincatherinemt therapeuticdrugmonitoringofganciclovirtreatmentforcytomegalovirusinfectionsamongimmunocompromisedchildren
AT knackstedtelizabethd therapeuticdrugmonitoringofganciclovirtreatmentforcytomegalovirusinfectionsamongimmunocompromisedchildren
AT hershadaml therapeuticdrugmonitoringofganciclovirtreatmentforcytomegalovirusinfectionsamongimmunocompromisedchildren
AT paviaandrewt therapeuticdrugmonitoringofganciclovirtreatmentforcytomegalovirusinfectionsamongimmunocompromisedchildren
AT spigarellimichaelg therapeuticdrugmonitoringofganciclovirtreatmentforcytomegalovirusinfectionsamongimmunocompromisedchildren